Moreover, BC in stages II, III, and IV had higher concentrations of SAA2 compared to the control group and stage I. Additionally, patients with BC who have lymph node involvement or distant metastases show elevated concentrations of SAA2 [39]. This evidence concerns the gene SAA2 and breast cancer.